Spots Global Cancer Trial Database for pharmacogenomics
Every month we try and update this database with for pharmacogenomics cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215) | NCT01521780 | Hepatocellular ... | MRI Pathology Blood Samples Blood Samples | 18 Years - | Merck Sharp & Dohme LLC | |
| Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) | NCT03150004 | Acute Myeloid L... Myelodysplastic... | Cladribine, Cyt... Cladribine and ... | 18 Years - | Medical College of Wisconsin | |
| Tamoxifen Pharmacogenetics in Asian Breast Cancer Women | NCT01181518 | Poisoning by, A... | 18 Years - | Inje University | ||
| Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia | NCT04770922 | Acute Lymphobla... Adverse Drug Ev... | - 21 Years | Cipherome, Inc. | ||
| Predictive Value of Drug Elimination Gene Polymorphisms on Clearance and Dose Adjustment of Sunitinib in Cancer Patients | NCT01098903 | Cancer | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | ||
| Chemical and Genetic Effects of the Experimental Anti-Cancer Drugs in Cheek Cells in Cancer Patients | NCT00055380 | Cancer | Oral cytobrushi... | - | National Institutes of Health Clinical Center (CC) | |
| Study to Evaluate Markers of Response in Locally Advanced Breast Cancer | NCT01338753 | Breast Neoplasm... | Bevacizumab, do... | 18 Years - 70 Years | Clinica Universidad de Navarra, Universidad de Navarra | |
| Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) | NCT03150004 | Acute Myeloid L... Myelodysplastic... | Cladribine, Cyt... Cladribine and ... | 18 Years - | Medical College of Wisconsin | |
| Pharmacogenomics IND EXEMPT SNP Clinical Study - Alectinib and Single Nucleotide Polymorphisms | NCT05987956 | Non-small Cell ... | Alectinib - Usu... Alectinib - Stu... | 22 Years - 75 Years | Medicine Invention Design, Inc | |
| ALL SCTped FORUM - Pharmacogenomic Study (add-on Study) | NCT02670564 | Acute Lymphobla... | Pharmacogenomic... Busulfan plasma... | - 18 Years | Swiss Pediatric Oncology Group | |
| Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) | NCT03150004 | Acute Myeloid L... Myelodysplastic... | Cladribine, Cyt... Cladribine and ... | 18 Years - | Medical College of Wisconsin | |
| Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery | NCT03455751 | Colorectal Canc... Diverticular Di... Crohn Disease Ulcerative Coli... | PGx-guided post... | 18 Years - 80 Years | The Cleveland Clinic | |
| Genotyping Analysis of Acute Lymphoblastic Leukemia | NCT00961285 | Acute Lymphobla... Adult | 18 Years - | University of Bologna | ||
| DHPLC Determination of TPMT Polymorphisms. | NCT00402090 | Acute Lymphobla... | 18 Years - | National Institute of Cancerología | ||
| Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy | NCT02492360 | Peripheral Nerv... Testicular Neop... | Blood sample co... Report of perip... | 18 Years - | Indiana University | |
| Chemical and Genetic Effects of the Experimental Anti-Cancer Drugs in Cheek Cells in Cancer Patients | NCT00055380 | Cancer | Oral cytobrushi... | - | National Institutes of Health Clinical Center (CC) | |
| Avera Cancer Sequencing and Analytics Protocol (ASAP) | NCT05142033 | Cancer Cancer Diagnosi... Early Detection... Breast Cancer Lung Cancer Colon Cancer GI Cancer Gynecologic Can... Ovarian Cancer Endometrial Can... CNS Cancer Hematologic Can... | 18 Years - | Avera McKennan Hospital & University Health Center | ||
| Genotyping Analysis of Acute Lymphoblastic Leukemia | NCT00961285 | Acute Lymphobla... Adult | 18 Years - | University of Bologna | ||
| Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215) | NCT01521780 | Hepatocellular ... | MRI Pathology Blood Samples Blood Samples | 18 Years - | Merck Sharp & Dohme LLC | |
| Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) | NCT03150004 | Acute Myeloid L... Myelodysplastic... | Cladribine, Cyt... Cladribine and ... | 18 Years - | Medical College of Wisconsin | |
| Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia | NCT04770922 | Acute Lymphobla... Adverse Drug Ev... | - 21 Years | Cipherome, Inc. | ||
| Safety of Batracylin in Patients With Solid Tumors and Lymphomas | NCT00450502 | Neoplasms | Batracylin | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy | NCT02564484 | Leukemia Lymphoma | 18 Years - | St. Jude Children's Research Hospital | ||
| Pharmacogenomics IND EXEMPT SNP Clinical Study - Abiraterone and Single Nucleotide Polymorphisms | NCT03348670 | Prostate Cancer | Abiraterone - U... Abiraterone - S... | 22 Years - 75 Years | Medicine Invention Design, Inc | |
| Pharmacogenomic Study in Myeloma Patients Treated With Melphalan-prednisone-thalidomide or Lenalidomide-dexamethasone | NCT00907452 | Myeloma | melphalan-predn... lenalidomide-de... | 65 Years - | Intergroupe Francophone du Myelome | |
| Pharmacogenomics IND EXEMPT SNP Clinical Study - Abiraterone and Single Nucleotide Polymorphisms | NCT03348670 | Prostate Cancer | Abiraterone - U... Abiraterone - S... | 22 Years - 75 Years | Medicine Invention Design, Inc | |
| Study to Evaluate Markers of Response in Locally Advanced Breast Cancer | NCT01338753 | Breast Neoplasm... | Bevacizumab, do... | 18 Years - 70 Years | Clinica Universidad de Navarra, Universidad de Navarra |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
